A review of monoaminergic neuropsychopharmacology in zebrafish

Zebrafish

Volumn 7, Issue 4, 2010, Pages 359-378

  Maximino, Caio ^a,b   Herculano, Anderson Manoel ^a,b  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b Zebrafish Neuroscience Research Consortium   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ANIMAL; ANIMAL BEHAVIOR; ANIMAL MODEL; HUMAN; METHODOLOGY; NEUROPHARMACOLOGY; REVIEW; ZEBRA FISH;

ANIMALS; BEHAVIOR, ANIMAL; HUMANS; MODELS, ANIMAL; NEUROPHARMACOLOGY; NEUROTRANSMITTER AGENTS; ZEBRAFISH;

DANIO RERIO; VERTEBRATA;

EID: 78650333768     PISSN: 15458547     EISSN: None     Source Type: Journal    
DOI: 10.1089/zeb.2010.0669     Document Type: Review

References (254)

1. Uhlm GR. Neurotransmitter transporter (plus): a promising new gene family. Trends Neurosci 1992;15:265-268.
2. Amara SG, Kuhar MJ. Neurotransmitter transporters: recent progress. Annu Rev Neurosci 1993;16:73-93.
3. De La Torre J. Dynamics of Brain Monoamines. New York: Springer, 1972.
4. Simon P, Dupuis R, Costentin J. Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 1994;61:59-64.
5. Graeff FG, Viana MB, Mora PO. Dual role of 5-HT in defense and anxiety. Neurosci Biobehav Rev 1997;21:791-799.
6. Lucki I. The spectrum of behaviors influence by serotonin. Biol Psychiatry 1998;44:151-162.
7. Ollat H, Pirot S. Antidépresseurs, sérotonine et anxiété. Neuropsychiatr Tendances Débats 2003;19:21-29.
8. Schildkraut JJ, Kety SS. Biogenic amines and emotion. Science 1967;156:21-30.
9. Schwartz JC. Histaminergic mechanisms in brain. Annu Rev Pharmacol Toxicol 1977;17:325-339.
10. Robbins TW. Cortical noradrenaline, attention and arousal. Psychol Med 1984;14:13-21.
11. Wada H, Inagaki N, Yamatodani A, Watanabe T. Is the histaminergic neuron system a regulatory center for wholebrain activity? Trends Neurosci 1991;14:415-418.
12. Horvitz JC. Mesolimbic and nigrostriatal dopamine responses to salient non-reward events. Neuroscience 2000;96:651-656.
13. Haas H, Panula P. The role of histamine and the tuberomamillary nucleus in the nervous system. Nat Rev Neurosci 2003;4:121-130.
14. Glavin GB. Stress and brain noradrenaline: a review. Neurosci Biobehav Rev 1985;9:233-243.
15. Willner P, Golembiowska K, Klimek V, Muscat R. Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology 1991;19:79-84.
16. Puri S, Ray A, Chakravarty AK, Sen P. Role of histaminergic mechanisms in the regulation of some stress responses in rats. Pharmacol Biochem Behav 1991;39:847-850.
17. Puri S, Ray A, Chakravarty AK, Sen P. Role of dopaminergic mechanisms in the regulation of stress responses in experimental animals. Pharmacol Biochem Behav 1994;48:53-56.
18. Chaouloff F. Serotonin, stress and corticoids. J Psychopharmacol 2000;14:139-151.
19. Dayan P, Huys QJM. Serotonin, inhibition, and negative mood. PLoS Comput Biol 2008;4:e4.
20. Mason ST. Noradrenaline: reward or extinction? Neurosci Biobehav Rev 1979;3:1-10.
21. Huston JP, Wagner U, Hasenöhrl RU. The tuberomammilary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav Brain Res 1997;83:97-105.
22. Ikemoto S, Panksepp J. The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Rev 1999;31:6-41.
23. Bizot J-C, Le Bihan C, Puech AJ, Hamon M, Thiébot M-H. Serotonin and tolerance to delay of reward in rats. Psychopharmacology 1999;146:400-412.
24. Berridge KC. The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology 2007; 191:391-431.
25. Montague PR, Hyman SE, Cohen JD. Computational roles for dopamine in behavioural control. Nature 2004;431: 760-767.
26. Nelson DK, Gehlert DR. Central nervous system biogenic amine targets for control of appetite and energy expenditure. Endocrine 2006;29:49-60.
27. Ursin R. Serotonin and sleep. Sleep Med Rev 2002;6:55-67.
28. Ouyang M, Hellman K, Abel T, Thomas SA. Adrenergic signaling plays a critical role in the maintenance of waking and in the regulation of REM sleep. J Neurophysiol 2004; 92:2071-2082.
29. Scheer FA, Czeisler CA. Melatonin, sleep, and circadian rhythms. Sleep Med Rev 2005;9:5-9.
30. Oganesyan GA, Romanova IV, Aristakesyan EA, Kuzik VV, Makina DM, Yu IM, et al. The dopaminergic system of the telencephalo-diencephalic areas of the vertebrate brain in the organization of the sleep-waking cycle. Neurosci Behav Physiol 2008;39:805-817.
31. Barone P, Davis TA, Braun AR. Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions. Eur J Pharmacol 1986;123: 109-114.
32. Jacobs BL, Fornal CA. Serotonin and motor activity. Curr Opin Neurobiol 1997;7:820-825.
33. Chiavegatto S, Nasello AG, Bernardi MM. Histamine and spontaneous motor activity: biphasic changes, receptors involved and participation of the striatal dopamine system. Life Sci 1998;62:1875-1888.
34. Jacobs BL, Fornal CA. Activity of serotonergic neurons in behaving animals. Neuropsychopharmacology 1999;21: 9S-15S.
35. Meneses A. 5-HT system and cognition. Neurosci Biobehav Rev 1999;23:1111-1125.
36. Nathan PJ, Sitaram G, Stough C, Silberstein RB, Sali A. Serotonin, noradrenaline and cognitive function: a preliminary investigation of the acute pharmacodynamic effects of a serotonin versus a serotonin and noradrenaline reuptake inhibitor. Behav Pharmacol 2000;11:639-642.
37. Passani MB, Bacciottini L, Mannaioni PF, Blandina P. Central histaminergic system and cognition. Neurosci Biobehav Rev 2000;24:107-113.
38. Grunwald DJ, Eisen JS. Headwaters of the zebrafish-emergence of a new model vertebrate. Nat Rev Genet 2002;3:717-724.
39. Li C, Lin WS, McGrath P. Whole zebrafish cytochrome P450 microplate assays for assessing drug metabolism and drug safety. Toxicologist 2009;97:S148.
40. Bresolin T, Rebelo MDF, Bainy ACD. Expression of PXR, CYP3A and MDR1 genes in liver of zebrafish. Comp Biochem Physiol Part C Toxicol Pharmacol 2005;140:403-407.
41. Tseng H-P, Hseu T-H, Buhler DR, Wang W-D, Hu C-H. Constitutive and xenobiotics-induced expression of a novel CYP3A gene from zebrafish larva. Toxicol Appl Pharmacol 2005;205:247-258.
42. Jeong J-Y, Kwon H-B, Ahn J-C, Kang D, Kwon SH, Park JA, et al. Functional and developmental analysis of the blood-brain barrier in zebrafish. Brain Res Bull 2008;28: 619-628.
43. Bjerke S. Developing Behavioral Assays to Study Dopamine-Related Disorders in Zebrafish (Danio rerio). Olso: The University of Oslo, 2002.
44. Dugatkin LA, McCall MA, Gregg RG, Cavanaugh A, Christensen C, Unseld M. Zebrafish (Danio rerio) exhibit individual differences in risk-taking behavior during predator inspection. Ethol Ecol Evol 2005;17:77-81.
45. Blaser RE, Gerlai R. Behavioral phenotyping in zebrafish: comparison of three behavioral quantification methods. Behav Res Methods 2006;38:456-469.
46. Wright D. Repeated measures of shoaling tendency in zebrafish (Danio rerio) and other small teleost fishes. Nat Protoc 2006;1:1828-1831.
47. Barcellos LJG, Ritter F, Kreutz LC, Quevedo RM, Silva LB, Bedin AC, et al. Whole-body cortisol increases after direct and visual contact with a predator in zebrafish. Aquaculture 2007;272:774-778.
48. Levin ED, Bencan Z, Cerutti DT. Anxiolytic effects of nicotine in zebrafish. Physiol Behav 2007;90:54-58.
49. Shang EH, Zhdanova IV. The circadian system is a target and modulator of prenatal cocaine effects. PLoS ONE 2007; 2:e587.
50. Xu X, Scott-Scheiern T, Kempker L, Simons K. Active avoidance conditioning in zebrafish (Danio rerio). Neurobiol Learn Mem 2007;87:72-77.
51. Yokogawa T, Marin W, Faraco J, Pézeron G, Appelbaum L, Zhang J, et al. Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoS Biol 2007; 5:e277.
52. Bass SL, Gerlai R. Zebrafish (Danio rerio) responds differentially to stimulus fish: the effects of sympatric and allopatric predators and harmless fish. Behav Brain Res 2008; 186:107-117.
53. Echevarria DJ, Hammack CM, Pratt DW, Hosemann JD. A novel test battery to assess global drug effects using the zebrafish. Int J Comp Psychol 2008;21:19-34.
54. Speedie N, Gerlai R. Alarm substance induced behavioral responses in zebrafish (Danio rerio). Behav Brain Res 2008; 188:168-177.
55. Gerlai R, Fernandes Y, Pereira T. Zebrafish (Danio rerio) responds to the animated image of a predator: towards the development of an automated aversive task. Behav Brain Res 2009;201:318-324.
56. Peng J, Wagle M, Mueller T, Mathur P, Lockwood BL, Bretaud S, et al. Ethanol-modulated camouflage response screen in zebrafish uncovers a novel role for cAMP and extracellular signal-regulated kinase signaling in behavioral sensitivity to ethanol. J Neurosci 2009;29:8408-8418.
57. Blaser RE, Chadwick L, McGinnis GC. Behavioral measures of anxiety in zebrafish (Danio rerio). Behav Brain Res 2010; 208:56-62.
58. Cachat J, Canavello P, Elegante M, Bartels B, Hart P, Bergner C, et al. Modeling withdrawal syndrome in zebrafish. Behav Brain Res 2010;208:371-376.
59. Wong K, Elegante M, Bartels B, Elkhayat S, Tien D, Roy S, et al. Analyzing habituation responses to novelty in zebrafish (Danio rerio). Behav Brain Res 2010;208:450-457.
60. Grossman L, Utterback E, Stewart A, Gaikwad S, Wong K, Elegante M, et al. Characterization of behavioral and endocrine effects of LSD on zebrafish. Behav Brain Res 2010; 214:277-284.
61. Maximino C, Brito TM, Dias CAGM, Gouveia A Jr., Morato S. Scototaxis as anxiety-like behavior in fish. Nat Protoc 2010;5:209-216.
62. Wong K, Stewart A, Gaikwad S, Gilder T, Wu N, Frank K, et al. Modeling seizure-related behavioral and endocrine phenotypes in adult zebrafish. Brain Res 2010;1348: 209-215.
63. Grimsby J, Chen K, Wang LJ, Lan NC, Shih JC. Human monoamine oxidase A and B genes exhibit identical exonintron organization. Proc Natl Acad Sci U S A 1991;88: 3637-3641.
64. Ekblom J, Jossan SS, Berstrüm M, Oreland L, Walum E, Aquilonius S-M. Monoamine oxidase-B in astrocytes. Glia 1993;8:122-132.
65. Edmondson DE, Binda C, Wang J, Upadhyay AK, Mattevi A. Molecular and mechanistic properties of the membranebound mitochondrial monoamine oxidases. Biochemistry 2009;48:4220-4230.
66. Anichtchik OV, Sallinen V, Peitsaro N, Panula P. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio). J Comp Neurol 2006;498: 593-610.
67. Setini A, Pierucci F, Senatori O, Nicotra A. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). Comp Biochem Physiol Part B Biochem Mol Biol 2005;140:153-161.
68. Kaslin J, Panula P. Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio). J Comp Neurol 2001;440:342-377.
69. Lillesaar C, Stigloher C, Tannhäuser B, Wulllimann MF, Bally-Cuif L. Axonal projections of raphe serotonergic neurons in the developing and adult zebrafish, Danio rerio, visualized by transgenic demonstration of raphe-specific pet1 expression. J Comp Neurol 2009;512:158-182.
70. Northcutt RG, Bradford MR Jr. New observations on the organization and evolution of the telencephalon of actinopterygian fishes. In: Ebbeson SOE, ed. Comparative Neurology of the Telencephalon. New York: Plenum Press, 1980, pp. 41-98.
71. Echteler SM, Saidel WM. Forebrain connections in the zebrafish support telencephalic homologies with land vertebrates. Science 1981;212:683-685.
72. Portavella M, Vargas JP, Torres B, Salas C. The effects of telencephalic pallial lesions on spatial, temporal, and emotional learning in goldfish. Brain Res Bull 2002;57:397-399.
73. Mueller T, Wullimann MF. An evolutionary interpretation of teleostean forebrain anatomy. Brain Behav Evol 2009; 74:30-42.
74. Adolf B, Chapouton P, Lam CS, Topp S, Tannhäuser B, Strähle U, et al. Conserved and acquired features of adult neurogenesis in the zebrafish telencephalon. Dev Biol 2006;295:278-293.
75. Wullimann MF. Secondary neurogenesis and telencephalic organization in zebrafish and mice: a brief review. Integr Zool 2009;4:123-133.
76. Grandel H, Kaslin J, Ganz J, Wenzel I, Brand M. Neural stem cells and neurogenesis in the adult zebrafish brain: origin, proliferation dynamics, migration and cell fate. Dev Biol 2006;295:263-277.
77. Zupanc GKH, Hinsch K, Gage FH. Proliferation, migration, neuronal differentiation, and long-term survival of new cells in the adult zebrafish brain. J Comp Neurol 2005;488:290-319.
78. Sallinen V, Sundvik M, Reenilä I, Peitsaro N, Khrustalyov D, Anichtchik OV, et al. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J Neurochem 2009;109:403-415.
79. Panula P, Chen Y-C, Priyadarshini M, Kudo H, Semenova S, Sundvik M, et al. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 2010;40: 46-57.
80. Paiva TB, Tominaga M, Paiva ACM. Ionization of histamine, N-acetylhistamine, and their iodinated derivatives. J Med Chem 1970;13:689-692.
81. Merickel A, Edwards RH. Transport of histamine by vesicular monoamine transporter-2. Neuropharmacology 1995;34:1543-1547.
82. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M. Histaminergic transmission in the mammalian brain. Physiol Rev 1991;71:1-51.
83. Waldmeier PC, Feldtrauer J-J, LaMaitre L. Methylhistamine: evidence for selective deamination by MAO B in the rat brain in vivo. J Neurochem 1977;29:785-790.
84. Husztu Z, Rimanóczy Á , Juhász A, Magyar K. Uptake, metabolism, and release of [3H]-histamine by glial cells in primary cultures of chicken cerebral hemispheres. Glia 2004;3:159-168.
85. Jonker JW, Schinkel AH. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharmacol Exp Ther 2004; 308:2-9.
86. Ericson H, Watanabe T, Köhler C. Morphological analysis of the tuberomammillary nucleus in the rat brain: delineation of subgroups with antibody against L-histidine decarboxylase as a marker. J Comp Neurol 1987;263:1-24.
87. Takagi H, Miroshima Y, Matsuyama T, Hayashi H, Watanabe T, Wada H. Histaminergic neurons in the neostriatum and cerebral cortex of the rat: a correlated light and electron microscopic immunocytochemical study using histidine decarboxylase as a marker. Brain Res 1986;364: 155-168.
88. Ericson H, Kohler C, Blomqvist A. GABA-like immunoreactivity in the tuberomammillary nucleus: an electron microscopic study in the rat. J Comp Neurol 1991;305:462-469.
89. Airaksinen MS, Alanen S, Szabat E, Visser TJ, Panula P. Multiple neurotransmitters in the tuberomammillary nucleus: comparison of rat, mouse, and guinea pig. J Comp Neurol 1992;323:103-116.
90. Kukko-Lukjanov TK, Panula P. Subcellular distribution of histamine, GABA and galanin in tuberomammillary neurons in vitro. J Chem Neuroanat 2003;25:279-292.
91. Patel BT, Tudball N, Wada H, Watanabe T. Adenosine deaminase and histidine decarboxylase coexist in certain neurons of the rat brain. Neurosci Lett 1986;63:185-189.
92. Mitsuchashi M, Payan DG. Molecular and cellular analysis of histamine H1 receptors on cultured smooth muscle cells. J Cell Biochem 1989;40:183-192.
93. Weiger T, Stevens DR, Wunder L, Haas HL. Histamine H1 receptors in C6 glial cells are coupled to calcium-dependent potassium channels via release of calcium from internal stores. Naunyn Schmiedebergs Arch Pharmacol 1997; 355:559-565.
94. Hösli E, Hösli L. Autoradiographic localization of binding sites for [3H]histamine and H1-and H2-antagonists on cultured neurones and glial cells. Neuroscience 1984;13: 863-870.
95. Arrang JM, Garbarg M, Schwartz JC. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 1983;302:832-837.
96. Schilicker E, Betz R, Gothert M. Histamine H3 receptormediated inhibition of serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch Pharmacol 1988;337: 588-592.
97. Schilicker E, Fink K, Hinterthaner M, Gothert M. Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3-receptors. Naunyn Schmiedebergs Arch Pharmacol 1989;340:633-638.
98. Ligneau X, Lin J-S, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, et al. Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist. J Pharmacol Exp Ther 1998;287:658-688.
99. Prast H, Argyriou A, Phillippu A. Histaminergic neurons facilitate social memory in rats. Brain Res 1996;734:316-318.
100. Silva WC, Bonini JS, Bevilaqua LRM, Izquierdo I, Cammarota M. Histamine enhances inhibitory avoidance memory consolidation through a H2 receptor-dependent mechanism. Neurobiol Learn Mem 2006;86:100-106.
101. Seltzer AM, Donoso AO, Podestá E. Restraint stress stimulation of prolactin and ACTH secretion: role of brain histamine. Physiol Behav 1986;36:251-255.
102. Knigge U, Warberg J. Minireview: the role of histamine in the neuroendocrinology of pituitary hormone secretion. Acta Endocrinol 1991;124:609-619.
103. Malmberg-Aiello P, Lamberti C, Pipponi A, Hänninen J, Ghelardini C, Bartolini A. Effects of two histamine-Nmethyltransferase inhibitors, SKF 91488 and BW 301U, in rodent antinociception. Naunyn Schmiedebergs Arch Pharmacol 1997;355:354-360.
104. Eriksson KS, Peitsaro N, Karlstedt K, Kaslin J, Panula P. Development of the histaminergic neurons and expression of histidine decarboxylase mRNA in the zebrafish brain in the absence of all peripheral histaminergic systems. Eur J Neurosci 1998;10:3799-3812.
105. Peitsaro N, Kaslin J, Anichtchik OV, Panula P. Modulation of the histaminergic system and behaviour by a-fluoromethylhistidine in zebrafish. J Neurochem 2004;86: 432-441.
106. Mochizuki T, Yamatodani A, Okakura K, Horii A, Inagaki N, Wada H. Circadian rhythm of histamine release from the hypothalamus of freely moving rats. Physiol Behav 1992;51:391-394.
107. Cahill GM, Hurd MW, Batchelor MM. Circadian rhythmicity in the locomotor activity of larval zebrafish. Neuroreport 1998;9:3445-3449.
108. Hurd MW, Debruyne J, Straume M, Cahill GM. Circadian rhythms of locomotor activity in zebrafish. Physiol Behav 1998;65:465-472.
109. Peitsaro N, Sundvik M, Anichtchik OV, Kaslin J, Panula P. Identification of zebrafish histamine H1, H2 and H3 receptors and effects of histaminergic ligands on behavior. Biochem Pharmacol 2007;73:1205-1214.
110. Peitsaro N, Anichtchik OV, Panula P. Identification of a histamine H3-like receptor in the zebrafish (Danio rerio) brain. J Neurochem 2000;75:18-24.
111. Choich JA, El-Nabawi A, Silbergeld EK. Evidence of histamine receptors in fish brain using an in vivo [14C]2-deoxyglucose autoradiographic method and an in vitro receptor-binding autoradiographic method. Environ Res 2004;94:86-93.
112. Schenberg LC, Póvoa RMF, Caldellas AV, Tufik S, Bittencourt AS. Functional specializations within the tectum defense system of the rat. Neurosci Biobehav Rev 2005;29: 1279-1298.
113. Imaizumi M, Onodera K. The behavioral and biochemical effects of thioperamide, a histamine H3-receptor antagonist, in a light/dark test measuring anxiety in mice. Life Sci 1993;53:1675-1683.
114. Yokoyama F, Yamauchi M, Oyama M, Okuma K, Onozawa K, Nagayama T, et al. Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic. Psychopharmacology 2009;205:177-187.
115. Cofiel LPV, Mattioli R. L-histidine enhances learning in stressed zebrafish. Braz J Med Biol Res 2009;42:128-134.
116. Zhdanova IV. Sleep in zebrafish. Zebrafish 2006;3: 215-226.
117. Renier C, Mignot E. Pharmacogenomics of sleep-promoting drugs in zebrafish. Sleep 27.
118. Renier C, Faraco JH, Bourgin P, Motley T, Bonaventure P, Rosa F, et al. Genomic and functional conservation of sedative-hypnotic targets in the zebrafish. Pharmacogenetics Genomics 2007;17:237-253.
119. Candy J, Collet C. Two tyrosine hydroxylase genes in teleosts. Acta Biochim Biophys 2005;1721:35-44.
120. Norton WHJ, Folchert A, Bally-Cuif L. Comparative analysis of serotonin receptor (HTR1A/HTR1B families) and transporter (scl6a4a/b) gene expression in the zebrafish brain. J Comp Neurol 2008;511:521-542.
121. Filippi A, Mahler J, Schweitzer J, Driever W. Expression of the paralogous tyrosine hydroxylase encoding genes th1 and th2 reveals the full complement of dopaminergic and noradrenergic neurons in zebrafish larval and juvenile brain. J Comp Neurol 2010;418:423-438.
122. Yamamoto K, Ruuskanen JO, Wullimann MF, Vernier P. Two tyrosine hydroxylase genes in vertebrates-new dopaminergic territories revealed in the zebrafish brain. Mol Cell Neurosci 2010;43:394-402.
123. Sallinen V, Torkko V, Sundvik M, Reenilä I, Khrustalyov D, Kaslin J, et al. MPTP and MPP+ target specific aminergic cell populations in larval zebrafish. J Neurochem 2009; 108:719-731.
124. Kaslin J, Nystedt JM, Östergård M, Peitsaro N, Panula P. The orexin/hypocretin system in zebrafish is connected to the aminergic and cholinergic systems. J Neurosci 2004;24:2678-2689.
125. Meek J. Catecholamines in the brains of Osteichtyes (bony fishes). In: Smeets WJAJ, Reiner A, eds. Phylogeny and Development of Catecholamine Systems in the CNS of Vertebrates. Cambridge: Cambridge University Press, 1994, pp. 49-76.
126. Rink E, Wullimann MF. The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum). Brain Res 2001;889:316-330.
127. Rink E, Wullimann MF. Connections of the ventral telencephalon and tyrosine hydroxylase distribution in the zebrafish brain (Danio rerio) lead to identification of an ascending dopaminergic system in a teleost. Brain Res Bull 2002;57:385-387.
128. Rink E, Wullimann MF. Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study. Dev Brain Res 2002;137:89-100.
129. Ma PM. Catecholaminergic systems in the zebrafish. IV. Organization and projection pattern of dopaminergic neurons in the diencephalon. J Comp Neurol 2003;460:13-37.
130. MacLean DL, Fetcho JR. Relationship of tyrosine hydroxylase and serotonin immunoreactivity to sensorimotor circuitry in larval zebrafish. J Comp Neurol 2004;480: 57-61.
131. Przedborski S, Jackson-Lewis V. Mechanisms of MPTP toxicity. Mov Disord 1998;13:35-38.
132. Mathur P, Guo S. Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes. Neurobiol Dis 2010;40:66-72.
133. Anichtchik OV, Kaslin J, Peitsaro N, Scheinin M, Panula P. Neurochemical and behavioral changes in zebrafish Danio rerio after systemic administration of 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,5-tetrahydropyridine. J Neurochem 2004;88:443-453.
134. Bretaud S, Lee S, Guo S. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. Neurotoxicol Teratol 2004;26:857-864.
135. Fujii R. The regulation of motile activity in fish chromatophores. Pigment Cell Res 2000;13:300-319.
136. Wen L, Wei W, Gu W, Huang P, Ren X, Zhang Z, et al. Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish. Dev Biol 2008;314: 84-92.
137. McKinley ET, Baranowski TC, Blavo DO, Cato C, Doan TN, Rubinstein AL. Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Mol Brain Res 2005;141:128-137.
138. Lam CK, Korzh V, Strähle U. Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP. Eur J Neurosci 2005;21:1758-1762.
139. Guo S, Wilson SW, Cooke S, Chitnis AB, Driever W, Rosenthal A. Mutations in the zebrafish unsmask shared regulatory pathways controlling the development of catecholaminergic neurons. Dev Biol 1999;208:473-487.
140. Torres GE, Gainetdinov RR, Caron MG. Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 2003;4:13-25.
141. Inazu M, Kubota N, Takeda H, Zhang J, Kiuchi Y, Oguchi K, et al. Pharmacological characterization of dopamine transport in cultured rat astrocytes. Life Sci 1999;64: 2239-2245.
142. Holzschuh J, Ryu S, Aberger F, Driever W. Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo. Mech Dev 2001;101:237-243.
143. Thirumalai V, Cline HT. Endogenous dopamine suppresses initiation of swimming in prefeeding zebrafish larvae. J Neurophysiol 2008;100:473-487.
144. Irons TD, MacPhail RC, Hunter DL, Padilla S. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol Teratol 2010;32:84-90.
145. López-Patiño MA, Yu L, Cabral H, Zhdanova IV. Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol Behav 2008;93:160-171.
146. Schetz JA, Sibley DR. Dopaminergic neurotransmission. In: Sibley DR, Hanin I, Kuhar M, Skolnick P, eds. Handbook of Contemporary Neuropharmacology. Hoboken: John Wiley & Sons, Inc., 2007, pp. 221-256.
147. Pickel VM. Extrasynaptic distribution of monoamine transporters and receptors. In: Agnati LF, Fuxe K, Nicholson C, Syková E, eds. Progress in Brain Research. New York: Elsevier, 2000, pp. 267-276.
148. Le Crom S, Kapsimali M, Baróme P-O, Vernier P. Dopamine receptors for every species: gene duplications and functional diversification in Craniates. J Struct Funct Genomics 2003;3:161-176.
149. Boehmler W, Obrech-Pflumio S, Canfield V, Thisse C, Thisse B, Levenson R. Evolution and expression of D2 and D3 dopamine receptor genes in zebrafish. Dev Dyn 2004;230:481-492.
150. Boehmler W, Carr T, Thisse C, Thisse B, Canfield V, Levenson R. D4 dopamine receptor genes of zebrafish and effects of the antipsychotic clozapine on larval swimming behaviour. Genes Brain Behav 2007;6:155-166.
151. Giacomini NJ, Rose B, Kobayashi K, Guo S. Antipsychotics produce locomotor impairment in larval zebrafish. Neurotoxicol Teratol 2006;28:245-250.
152. Seibt KJ, Oliveira RL, Zimmermann FF, Capiotti KM, Bogo MR, Ghisleni G, et al. Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio). Behav Brain Res 2010;214: 417-422.
153. Antoniou K, Kafetzopoulos E, Papadopoulou-Daifoti Z, Hyphantis T, Marselos M. D-amphetamine, cocaine, and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats. Neurosci Biobehav Rev 1998;23:189-196.
154. Seibt KJ, Oliveira RL, Rico EP, Dias RD, Bogo MR, Bonan CD. Antipsychotic drugs inhibit nucleotide hydrolysis in zebrafish (Danio rerio) brain membranes. Toxicol In Vitro 2009;23:78-92.
155. Ferré S, Fuxe K, von Euler G, Johansson B, Fredholm BB. Adenosine-dopamine interactions in the brain. Neuroscience 2009;51:501-512.
156. Seibt KJ, Oliveira RL, Rico EP, Dias RD, Bogo MR, Bonan CD. Typical and atypical antipsychotics alter acetylcholinesterase activity and ache expression in zebrafish (Danio rerio) brain. Comp Biochem Physiol Part C Toxicol Pharmacol 2009;150:10-15.
157. Li P, Shah S, Huang L, Carr AL, Gao Y, Thisse C, et al. Cloning and spatial and temporal expression of the zebrafish dopamine D1 receptor. Dev Dyn 2007;236:1339-1346.
158. Panula P, Chen Y-C, Priyadarshini M, Kudo H, Semenova S, Sundvik M, et al. The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 2010;40: 46-57.
159. Vincent JD, Cardinaud B, Vernier P. Evolution des ré-cepteurs de las monoamines et l'origine des systèmes motivationnels et émotionnels chez les vertébrés. Bull Acad Natl Med 1998;182:1505-1514.
160. Aston-Jones G. Locus coeruleus, A5 and A7 noradrenergic cell groups. In: Paxinos G, ed. The Rat Nervous System, 3rd edition. New York: Elsevier, 2004, pp. 259-294.
161. Byrum CE, Guyenet PG. Afferent and efferent connections of the A5 noradrenergic cell group in the rat. J Comp Neurol 1987;261:529-542.
162. Bajic D, Proudfit HL. Projections of neurons in the periaqueductal gray to pontine and medullary catecholamine cell groups involved in the modulation of nociception. J Comp Neurol 1999;405:359-379.
163. Aston-Jones G, Bloom FE. Activity of norepinephrinecontaining locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1981;1:876-886.
164. Aston-Jones G, Bloom FE. Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. J Neurosci 1981;1:887-900.
165. Sackerman J, Donegan JJ, Cunningham CS, Nguyen NN, Lawless K, Long A, et al. Zebrafish behavior in novel environments: effects of acute exposure to anxiolytic compounds and choice of Danio rerio line. Int J Comp Psychol 2010;23:43-61.
166. Severisen K, Sinning S, Mü ller HK, Wiborg O. Characterisation of the zebrafish serotonin transporter functionally links TM10 to the ligand binding site. J Neurochem 2008;105:1794-1805.
167. Ruuskanen JO, Laurila J, Xhaard H, Rantanen V-V, Vuoriluoto K, Wurster S, et al. Conserved structural, pharmacological and functional properties among the three human and five zebrafish a2-adrenoceptors. Br J Pharmacol 2005;144:165-177.
168. Ruuskanen JO, Xhaard H, Marjamäki A, Salaneck E, Salminen T, Yan YL, et al. Identification of duplicated fourth a2-adrenergic receptor subtype by cloning and mapping of five receptor genes in zebrafish. Mol Biol Evol 2004;21: 14-28.
169. Ruuskanen JO, Peitsaro N, Kaslin J, Panula P, Scheinin M. Expression and function of a2-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions. J Neurochem 2005;94:1559-1569.
170. Ruxton GD, Speed MP, Kelly DJ. What, if anything, is the adaptive function of countershading? Anim Behav 2004;68:445-451.
171. Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas JP, et al. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 2000;35: 79-95.
172. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14:149-167.
173. Tanaka M, Yoshida M, Emoto H, Ishii H. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety: basic studies. Eur J Pharmacol 2000;405:397-406.
174. Wang Z, Nishimura Y, Shimada Y, Umemoto N, Hirano M, Zang L, et al. Zebrafish b-adrenergic receptor mRNA expression and control of pigmentation. Gene 2009;446:18-27.
175. Ampatzis K, Dermon CR. Regional distribution and cellular localization of b2-adrenoceptors in the adult zebrafish brain (Danio rerio). J Comp Neurol 2010;518:1418-1441.
176. Laming PR, Patrick E. Habituation of fright and arousal in the teleosts Carassius auratus and Rutilus rutilus. J Comp Physiol Psychol 1982;96:460-466.
177. Mann KD, Hoyt C, Feldman S, Blunt L, Raymond A, Page-McCaw PS. Cardiac response to startle stimuli in larval zebrafish: sympathetic and parasympathetic components. Am J Physiol Regul Integr Comp Physiol 2010;298:R1288-R1297.
178. Rooney DJ, Laming PR. Localization of telencephalic regions concerned with habituation of cardiac and ventilatory responses associated with arousal in the goldfish (Carassius auratus). Behav Neurosci 1986;100:45-50.
179. Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003;66:1673-1680.
180. Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003;299:76.
181. Bellipanni G, Rink E, Bally-Cuif L. Cloning of two tryptophan hydroxylase genes expressed in the diencephalon of the developing zebrafish brain. Mech Dev 2002;119: S215-S220. (Pubitemid 39658713)
182. Teraoka H, Russel C, Regan J, Chandrasekhar A, Concha ML, Yokoyama R, et al. Hedgehog and Fgf signaling pathways regulate the development of tphR-expressing serotonergic raphe neurons in zebrafish embryos. J Neurobiol 2004;60:275-288.
183. Lillesaar C, Tannhäuser B, Stigloher C, Kremmer E, Bally-Cuif L. The serotonergic phenotype is acquired by converging genetic mechanisms within the zebrafish central nervous system. Dev Dyn 2007;236:1072-1084.
184. Parent A. Comparative anatomy of the serotoninergic systems. J Physiol (Paris) 1981;77:147-156.
185. Butler AB, Hodos W. Comparative Vertebrate Neuroanatomy: Evolution and Adaptation. Hoboken: John Wiley & Sons, 2005.
186. Facchin L, Burgess HA, Siddiqi M, Granato M, Halpern ME. Determining the function of zebrafish epithalamic asymmetry. Philos Trans R Soc B 2009;364:1021-1032.
187. Brustein E, Chong M, Holmqvist B, Drapeau P. Serotonin patterns locomotor network activity in the developing zebrafish by modulating quiescent periods. J Neurobiol 2003;57:303-322.
188. Gabriel JP, Mahmood R, Kyriakatos A, Söll I, Hauptmann G, Calabrese
189. Brustein E, Drapeau P. Serotoninergic modulation of chloride homeostasis during maturation of the locomotor network in zebrafish. J Neurosci 2005;25:10607-10616.
190. Wang Y, Takai R, Yoshioka H, Shirabe K. Characterization and expression of serotonin transporter genes in zebrafish. Tohoku J Exp Med 2006;208:267-274.
191. Airhart MJ, Lee DH, Wilson TD, Miller BE, Miller MN, Skalko RG. Movement disorders and neurochemical changes in zebrafish larvae after bath exposure to fluoxetine (PROZAC). Neurotoxicol Teratol 2007;29:652-664.
192. Brocco M, Dekeyne A, Veiga S, Girardon S, Millan MJ. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake: a pharmacological characterization of diverse classes of anti-depressant agents. Pharmacol Biochem Behav 2002;71: 667-680.
193. Sanchez C, Meier E. Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology 1997;129:197-205.
194. Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF, et al. Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res 2009;205:38-44.
195. Cachat JM, Canavello PR, Elegante MF, Bartels BK, Elkhayat SI, Hart PC, et al. Modeling stress and anxiety in zebrafish. In: Kalueff AV, Cachat J, eds. Zebrafish Models in Neurobehavioral Research. New York: Humana Press, 2010, pp. 73-88.
196. Krebs-Thomson K, Paulus MP, Geyer MA. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology 1998;18:339-351.
197. Meyer A, Schatrl M. Gene and genome duplications in vertebrates: the one-to-four (-to-eight in fish) rule and the evolution of novel gene functions. Curr Opin Cell Biol 1999;11:699-704.
198. Soderpalm B, Hjorth S, Engel JA. Effects of 5-HT1A receptor agonists and L-5-HTP in Montgomery's Conflict Test. Pharmacol Biochem Behav 1989;32:259-265.
199. Bencan Z, Sledge D, Levin ED. Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol Biochem Behav 2009;94:75-80.
200. Gebauer DL, Pagnussat N, Piato  L, Bonan CD, Lara DR. Assessment of anxiety in zebrafish (Danio rerio): similarities and differences between benzodiazepines and buspirone. Neuropsychopharmacology 2010 (In press). 201.
201. Klein DC, Moore RY. Indole metabolism in the pineal gland: a circadian rhythm in N-acetyltransferase. Science 1970;169:1093-1095.
202. Bégay V, Falcón J, Cahill GM, Klein DC, Coon SL. Transcripts encoding two melatonin synthesis enzymes in the teleost pineal organ: circadian regulation in pike and zebrafish, but not in trout. Endocrinology 1998;139:905-912.
203. Appelbaum L, Anzulovich A, Baler R, Gothilf Y. Homeobox-clock protein interaction in zebrafish: a shared mechanism for pineal-specific and circadian gene expression. J Biol Chem 2005;280:11544-11551.
204. Reppert SM, Weaver DR, Cassone VM, Godson C, Kolakowski LF Jr. Melatonin receptors are for the birds: molecular analysis of two receptor subtypes differentially expressed in chick brain. Neuron 1995;15:1003-1015.
205. Danilova N, Krupnik VE, Sugden D, Zhdanova IV. Melatonin stimulates cell proliferation in zebrafish embryo and accelerates its development. FASEB J 2004;18:751-753.
206. Dubocovich ML. Melatonin receptors in the central nervous system. In: Sibley DR, Hanin I, Kuhar MJ, Skolnick P, eds. Handbook of Contemporary Neuropharmacology. Hoboekn: John Wiley & Sons, Inc., 2007, pp. 37-77.
207. Zhdanova IV, Wang SY, Leclair OU, Danilova N. Melatonin promotes sleep-like state in zebrafish. Brain Res 2001;903:263-268.
208. Zhdanova IV, Sankrithi NS, Campos IB, O'Malley DM. Diurnal variation in the responsiveness of larval zebrafish to a photic stimulus. Sleep 2004;27:A281.
209. Rawashdesh O, de Borsetti NH, Roman G, Cahill GM. Melatonin suppresses nighttime memory formation in zebrafish. Science 2007;318:1144-1146.
210. Golombek DA, Pévet P, Cardinali DP. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci Biobehav Rev 1996;20:403-412.
211. Maximino C, Brito TM, Batista AWS, Herculano AM, Morato S, Gouveia A Jr. Measuring anxiety in zebrafish: a critical review. Behav Brain Res 2010;214:157-171.
212. Prober DA, Rihel J, Onah AA, Sung RJ, Schier AF. Hypocretin/ orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci 2006;26:13400-13410.
213. Langheinrich U. Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 2003;25:904-912.
214. Lockwood BL, Bjerke S, Kobayashi K, Guo S. Acute effects of alcohol on larval zebrafish: a genetic system for large-scale screening. Pharmacol Biochem Behav 2004;77: 647-654.
215. Rubinstein AL. Zebrafish assays for drug toxicity screening. Expert Opin Drug Metab Toxicol 2006;2:231-240.
216. Best JD, Alderton WK. Zebrafish: An in vivo model for the study of neurological diseases. Neuropsychiatr Dis Treat 2008;4:567-576.
217. Fero K, Yokogawa T, Burgess HA. The behavioural repertoire of larval zebrafish. In: Kalueff AV, Cachat J, eds. Zebrafish Models in Neurobehavioral Research. Cambridge: Cambridge University Press, 2010, pp. 249-292.
218. Norton W, Bally-Cuif L. Adult zebrafish as a model organism for behavioural genetics. BMC Neurosci 2010;11:90.
219. Wullimann MF, Rupp B, Reichert H. Neuroanatomy of the Zebrafish Brain: A Topological Atlas. Basel, Boston, Berlin: Birkhäuser Verlar, 1996.
220. Chen Z, Kamei C. Facilitating effects of histamine on spatial memory deficit induced by scopolamine in rats. Acta Pharmacol Sin 2000;21:814-818.
221. Chen Z, Sugimoto Y, Kamei C. Effects of histamine and its related compounds on impairment of passive avoidance response following hippocampal lesions in rats. J Brain Sci 1997;23:225-240.
222. Cacabelos R, Alvarez XA. Histidine decarboxylase inhibition induced by alpha-fluoromethylhistidine provokes learningrelated hypokinetic activity. Agents Actions 1991;33:131-134.
223. Ray A, Puri S, Chakravarty AK, Sen P. Central histaminergic involvement during stress in rats. Indian J Exp Biol 1992;30:724-728.
224. Chen Z, Sugimoto Y, Kamei C. Effects of intracerebroventricular injection of a-fluoromethylhistidine on radial maze performance in rats. Pharmacol Biochem Behav 1999;64:513-518. (Pubitemid 29488478)
225. Alvarez EO, Banzán AM. Histamine in dorsal and ventral hippocampus. II. Effects of H1 and H2 histamine antagonists on exploratory behavior in male rats. Physiol Behav 1986;37:39-45.
226. Gatti PJ, Gertner SB. Cardiovascular and behavioral actions of centrally administered cimetidine. J Cardiovasc Pharmacol 1984;6:575-581.
227. Bal A, Bachelot T, Savasta M, Manier M, Verna JM, Benabid AL, et al. Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies. Mol Brain Res 1994;23:204-212.
228. Smiley JF, Levey AI, Ciliax BJ, Goldman-Rakic PS. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci U S A 1994;91:5720-5724.
229. Gonon F. Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J Neurosci 1997;17:5972-5978.
230. Caille I, Dumartin B, Bloch B. Ultrastructural localization of D1 dopamine receptor immunoreactivity in rat striatonigral neurons and its relation with dopaminergic innervation. Brain Res 1996;730:17-31.
231. Miyazaki I, Asanuma M, Diaz-Corrales FJ, Miyoshi K, Ogawa N. Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res 2004;1029:120-123.
232. Negyessy L, Goldman-Rakic PS. Subcellular localization of the dopamine D2 receptor and coexistence with the calcium-binding protein neuronal calcium sensor-1 in the primate prefrontal cortex. J Comp Neurol 2005;488:464-475.
233. Tzchentke TM. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 1998;56:613-672.
234. Webb KJ, Norton WHJ, Trümbach D, Meijer AH, Ninkovic J, Topp S, et al. Zebrafish reward mutants reveal novel transcripts mediating the behavioral effects of amphetamine. Genome Biol 2009;10:R81.
235. Bredeloux P, Dubuc I, Costentin J. Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission. Br J Pharmacol 2007;150:711-719.
236. Darland T, Dowling JE. Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc Natl Acad Sci U S A 2001;98:11691-11696.
237. Eilam D, Szechtman H. Biphasic effect of D-2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 1989;28:151-157.
238. Navarro JF, Muñoz AL, Rivas T, Miñarro J, Simon VM. Efectos del haloperidol sobre la catalepsia en ratones macho. Psicothema 1992;4:369-377.
239. Gattaz WF, Schummer B, Behrens S. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats. J Neural Transm 1994;96: 227-232.
240. Hertz L, Lovatt D, Goldman SA, Nedergaard M. Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [CA2+]i. Neurochem Int 2010;57:411-420.
241. Shields AD, Wang Q, Winder DG. a2A-adrenergic receptors heterosynaptically regulate glutamatergic transmission in the bed nucleus of the stria terminalis. Neuroscience 2009;163:339-351.
242. Day HE, Campeau S, Watson SJ Jr., Akil H. Distribution of alpha 1a-, alpha 1b-and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat 1997;13:115-139.
243. Ampatzis K, Kentouri M, Dermon CR. Neuronal and glial localization of a2a-adrenoceptors in the adult zebrafish (Danio rerio) brain. J Comp Neurol 2008;508:72-93.
244. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805-809.
245. Doze VA, Chen B-X, Maze M. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology 1989;71:75-79.
246. Blanchard RJ, Taukulis HK, Rodgers RJ, Magee LK, Blanchard DC. Yohimbine potentiates active defensive responses to threatening stimuli in Swiss-Webster mice. Pharmacol Biochem Behav 1993;44:673-681.
247. Kirby DA, Pinto JM, Hottinger S, Johnson DA, Lown B. Behavioral arousal enhances inducibility and rate of ventricular tachycardia. Am J Physiol Heart Circ Physiol 1991;261:H1734-H1739.
248. Azmitia EC, Gannon PJ, Kheck NM, Whitaker-Azmitia PM. Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 1996;14:35-46.
249. Pazos A, Cortés R, Palacios JM. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 1985;346:231-249. (Pubitemid 16241112)
250. Barone P, Jordan D, Atger F, Kopp N, Fillion G. Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain. Brain Res 1994; 638:85-94.
251. Sari Y. Serotonin1B receptors: from protein to physiological function and behavior. Neurosci Biobehav Rev 2004;28: 565-582.
252. Amargos-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, et al. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex 2004;14:281-299.
253. Sugden D. Psychopharmacological effects of melatonin in mouse and rat. J Pharmacol Exp Ther 1983;227:587-591.
254. Argyriou A, Prast H, Phillippu A. Melatonin facilitates short-term memory. Eur J Pharmacol 1998;349:159-162.